Literature DB >> 18293137

Associations among correlates of schedule adherence to antiretroviral therapy (ART): a path analysis of a sample of crack cocaine using sexually active African-Americans with HIV infection.

J S Atkinson1, L Nilsson Schönnesson, M L Williams, S C Timpson.   

Abstract

Adherence to HIV medication regimens is a function of multiple dimensions including psychological functioning, social support, adherence self-efficacy and optimism regarding treatment. Active substance use can also negatively affect adherence. An understanding of the nature of the associations among the correlates of adherence can better inform the design of interventions to improve adherence. This study developed an exploratory path model of schedule adherence using data from a sample 130 African-American HIV-positive crack cocaine users on highly active antiretroviral therapy (ART). This model was based on the Transactional Model of Stress and Coping developed by Lazarus and Folkman. Following the theory, the effects of psychological distress on schedule adherence were mediated by patients' relationship with their doctor and optimism towards antiretroviral treatment. Adherence was also associated with patients' self-efficacy regarding their medical regimen which, in turn, was associated with their social support.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18293137      PMCID: PMC2860722          DOI: 10.1080/09540120701506788

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  70 in total

1.  Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS.

Authors:  S Bakken; W L Holzemer; M A Brown; G M Powell-Cope; J G Turner; J Inouye; K M Nokes; I B Corless
Journal:  AIDS Patient Care STDS       Date:  2000-04       Impact factor: 5.078

2.  Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?

Authors:  Mary Catherine Beach; Jeanne Keruly; Richard D Moore
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

3.  Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study.

Authors:  R Andersen; S Bozzette; M Shapiro; P St Clair; S Morton; S Crystal; D Goldman; N Wenger; A Gifford; A Leibowitz; S Asch; S Berry; T Nakazono; K Heslin; W Cunningham
Journal:  Health Serv Res       Date:  2000-06       Impact factor: 3.402

4.  Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use.

Authors:  M D Stein; J D Rich; J Maksad; M H Chen; P Hu; M Sobota; J Clarke
Journal:  Am J Drug Alcohol Abuse       Date:  2000-05       Impact factor: 3.829

5.  Perceived compliance with AZT dosing among a sample of African-American drug users.

Authors:  M Williams; A Bowen; M Ross; R Freeman; W Elwood
Journal:  Int J STD AIDS       Date:  2000-01       Impact factor: 1.359

6.  Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease.

Authors:  S L Catz; J A Kelly; L M Bogart; E G Benotsch; T L McAuliffe
Journal:  Health Psychol       Date:  2000-03       Impact factor: 4.267

7.  Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection.

Authors:  Geetanjali Chander; Bryan Lau; Richard D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

8.  Prediction of adherence to antiretroviral therapy: a one-year longitudinal study.

Authors:  G Godin; J Côté; H Naccache; L D Lambert; S Trottier
Journal:  AIDS Care       Date:  2005-05

9.  Baseline predictors of three types of antiretroviral therapy (ART) adherence: a 2-year follow-up.

Authors:  L Nilsson Schönnesson; P M Diamond; M W Ross; M Williams; G Bratt
Journal:  AIDS Care       Date:  2006-04

10.  Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease.

Authors:  Lena Nilsson Schönnesson; Mark L Williams; Michael W Ross; Pamela M Diamond; Blair Keel
Journal:  Int J STD AIDS       Date:  2007-06       Impact factor: 1.359

View more
  9 in total

1.  Social support as a predictor of early diagnosis, linkage, retention, and adherence to HIV care: results from the steps study.

Authors:  J Daniel Kelly; Christine Hartman; James Graham; Michael A Kallen; Thomas P Giordano
Journal:  J Assoc Nurses AIDS Care       Date:  2014-02-06       Impact factor: 1.354

2.  A binational study of patient-initiated changes to antiretroviral therapy regimen among HIV-positive Latinos living in the Mexico-U.S. border region.

Authors:  María Luisa Zúñiga; Fátima Muñoz; Justine Kozo; Estela Blanco; Rosana Scolari
Journal:  AIDS Behav       Date:  2012-08

Review 3.  A mixed-methods approach to synthesizing evidence on mediators of intervention effects.

Authors:  Jennifer Leeman; Yunkyung Chang; Corrine I Voils; Jamie L Crandell; Margarete Sandelowski
Journal:  West J Nurs Res       Date:  2011-03-17       Impact factor: 1.967

4.  Buffering effects of general and medication-specific social support on the association between substance use and HIV medication adherence.

Authors:  Keren Lehavot; David Huh; Karina L Walters; Kevin M King; Michele P Andrasik; Jane M Simoni
Journal:  AIDS Patient Care STDS       Date:  2011-03       Impact factor: 5.078

5.  The Lived Experience of a Newly Diagnosed Older Person With HIV in Ukraine.

Authors:  Amy Allen; Irina Zaviryukha; Tetiana Kiriazova; Sheela Shenoi; Julia Rozanova
Journal:  Qual Health Res       Date:  2021-08-20

6.  Perceived HIV Treatment Norms Modify the Association Between HIV-Related Stigma and Adherence to Antiretroviral Therapy Among Persons Living with HIV in Baltimore, Maryland.

Authors:  Abby E Rudolph; Robert S Dembo; Karin Tobin; Carl Latkin
Journal:  AIDS Behav       Date:  2021-08-02

7.  Three types of self-efficacy associated with medication adherence in patients with co-occurring HIV and substance use disorders, but only when mood disorders are present.

Authors:  Susan Reif; Rae Jean Proeschold-Bell; Jia Yao; Sara Legrand; Anna Uehara; Edgar Asiimwe; Evelyn Byrd Quinlivan
Journal:  J Multidiscip Healthc       Date:  2013-06-24

Review 8.  Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence.

Authors:  Lilla Náfrádi; Kent Nakamoto; Peter J Schulz
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

9.  Syndemic factors associated with adherence to antiretroviral therapy among HIV-positive adult heterosexual men.

Authors:  James M McMahon; Amy Braksmajer; Chen Zhang; Natalie Leblanc; Michael Chen; Angela Aidala; Janie Simmons
Journal:  AIDS Res Ther       Date:  2019-11-09       Impact factor: 2.250

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.